Latest Ataxia Stories
LONDON, March 26, 2015 /PRNewswire/ -- SummaryGlobalData's clinical trial report, "Spinocerebellar Ataxias Global Clinical Trials Review, H1, 2015" provides data on the Spinocerebellar
Scientists, physicians, patients, families, and community leaders from around the world will join together in Tampa Bay from September 4-6 for the Friedreich’s Ataxia Research Alliance’s (FARA)
'We Believe' is a viral social media campaign that sheds light on Friedreich's Ataxia, a rare genetic disease for which there is currently no treatment or cure.
At least one in 100 horses at some point in its life will lose the ability to control of its gait as a result of developing the neurological disorder ataxia.
The transfer, via a viral vector, of a normal copy of the gene deficient in patients, allowed to fully and very rapidly cure the heart disease in mice.
AAVLife aimed at advancing gene therapy for cardiomyopathy in Friedreich's ataxia to clinic DOWNINGTOWN, Pa., April 6, 2014 /PRNewswire-USNewswire/ -- The Friedreich's
EPI-743 gains key regulatory endorsement. Downingtown, PA, (PRWEB) March 19, 2014 Edison Pharmaceuticals announced today that the U.S.
EPI-743 in two phase 2 development studies for Friedreich's ataxia MOUNTAIN VIEW, Calif., March 17, 2014 /PRNewswire/ -- Edison Pharmaceuticals today announced that the United States
Researchers from North Carolina State University have found a link between a mutation in a gene called RAB 24 and an inherited neurodegenerative disease in Old English sheepdogs and Gordon setters.
EPI-743 phase 2b Friedreich's ataxia trial fully enrolled. Downingtown, PA (PRWEB) February 04, 2014 Edison Pharmaceuticals today announced that
- a slit in a tire to drain away surface water and improve traction.